BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 13, 2018
View Archived Issues
Forcing tumor cells to grow up
Read More
Preventing bacterial invisibility cloak
Read More
Targeting rare cells has large benefits
Read More
New mouse models demonstrate the role of HERV-W-Env in type 1 diabetes
Read More
Novel surgically induced rat model of diabetic nephropathy
Read More
Endogenous lipids stabilize GPCRs
Read More
Targeted radiotherapy with labeled NM-600 synergistic with immunotherapy in cancer model
Read More
Senescent cells-caused physical dysfunction and decreased survival are reversible with senolytics
Read More
Aurigene begins phase I trial of oral RORgammaT inverse agonist AUR-101
Read More
Phase I trial of OncoNano's tumor imaging agent ONM-100 begins
Read More
Compass Therapeutics set to advance next-generation antibody-based therapeutics into clinic
Read More
Oral tecovirimat is a putative antiviral treatment of smallpox
Read More
CohBar starts first-in-human testing of CB-4211 for the treatment of NASH
Read More
GlaxoSmithKline, Astex Therapeutics describe NRF2 activators
Read More
Beta Therapeutics divulges new heparanase inhibitors
Read More
Astellas' phase I study of ASP-1948 in advanced solid tumors enrolling patients
Read More
Yale University develops novel SV2A radiotracer for PET imaging of synaptic density
Read More
Positive topline data presented from second pivotal phase III study of ZX-008 in Dravet Syndrome
Read More
Audentes Therapeutics presents phase I/II data on AT-132 for XLMTM
Read More
Ono Pharmaceutical initiates phase I study of ONO-5788
Read More
N-Acetyl-beta-D-glucosaminidase inhibitors identified at Janssen
Read More
Lilly presents IDH1 and IDH2 mutant inhibitors
Read More
Shenzhen Chipscreen Biosciences patents indoleamine 2,3-dioxygenase 1 inhibitors
Read More
Roche presents phase II data for olesoxime in patients with SMA
Read More
Recruitment open for phase IIa study of Nerofe for AML and MDS
Read More
Jiangsu Wanbang Biopharmaceutical cleared to begin clinical trials of SGLT2 inhibitor in China
Read More
FDA approves Opdivo + Yervoy for MSI-H or dMMR metastatic colorectal cancer
Read More